Unbound MEDLINE

Multiple Sclerosis journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:Bookmark this site
Multiple Sclerosis[MH]| Refine this search
1 - 10 of 33870 journal articles in the PubMed databaseEmail to a friend    
 
Pachner AR, Warth JD, Pace A, et al. 
Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study. [Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Neurology 2009 Nov 3; 73(18):1493-500.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Pachner AR, Cadavid D, Wolansky L, et al. 
Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Neurology 2009 Nov 3; 73(18):1485-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Dalgas U, Stenager E, Jakobsen J, et al. 
Resistance training improves muscle strength and functional capacity in multiple sclerosis. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Neurology 2009 Nov 3; 73(18):1478-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Hughes B 
First oral therapies for multiple sclerosis anticipated. [Journal Article]
Nat Rev Drug Discov 2009 Nov; 8(11):831-3.
Full Citation | Find Related Articles 
Zagon IS, Rahn KA, Turel AP, et al. 
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis. [Journal Article]
Exp Biol Med (Maywood) 2009 Nov; 234(11):1383-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Petelin Gadze Z, Hajnsek S, Basic S, et al. 
Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case report. [JOURNAL ARTICLE]
BMC Neurol 2009 Oct 23; 9(1):56.
Abstract | Full Citation | Find Related Articles 
Hawker K, O'Connor P, Freedman MS, et al. 
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. [Clinical Trial, Phase II, Clinical Trial, Phase III, Comparative Study, Controlled Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Ann Neurol 2009 Oct; 66(4):460-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Hartung HP, Aktas O 
Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope. [Comment, Editorial]
Ann Neurol 2009 Oct; 66(4):429-32.
Full Citation | Publisher Full Text | Find Related Articles 
Trojano M, Pellegrini F, Paolicelli D, et al. 
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis. [Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't]
Ann Neurol 2009 Oct; 66(4):513-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Carpinella I, Cattaneo D, Abuarqub S, et al. 
Robot-based rehabilitation of the upper limbs in multiple sclerosis: feasibility and preliminary results. [Journal Article]
J Rehabil Med 2009 Nov; 41(12):966-70.
Abstract | Full Citation | Find Related Articles 
New Search Next Results
  

Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo


Advertise on this site.